NASDAQ Companies

Dose escalation in FHD-286 combination trial in AML continues to progress with clinical data expected in the second half of […]

Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in […]

ZUG, Switzerland, and BOSTON, USA, May 06, 2024 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or […]

Company Updates 2024 Outlook; Raises Adjusted EBITDA GuidanceNet Sales Driven by Volume-Based Growth Profitability Improvement Driven by Lower Input, Quality and […]

UrbanLink’s firm purchase order of 20 Lilium Jets, with an option for 20 more, includes scheduled pre-delivery payments. The agreement […]

MILAN, Italy and NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) — Genenta Science (NASDAQ: GNTA), a clinical-stage immuno-oncology company developing a cell-based […]

SINGAPORE and SHANGHAI, China, May 06, 2024 (GLOBE NEWSWIRE) — H World Group Limited (NASDAQ: HTHT and HKEX: 1179) (“H […]

PRINCETON, N.J., May 06, 2024 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, […]

 1000 Kazakh and international delegates participate in the annual conference, discussing artificial intelligence, big data analytics and app development in […]

Completion of the additional equity investment of $140M by AstraZeneca, as previously announced on November 1 and 15, 2023 NEW […]